Contact us to confirm your coverage
Patients with a personal or family history of thyroid cancer, multiple endocrine neoplasia type 2, or severe pancreatitis should not use tirzepatide
It also supports weight loss by improving metabolic rate to burn calories
While the FDA first approved GLP-1s in 2005, 6% of Americans are now on medications like Ozempic, Wegovy, Mounjaro, and Zepbound, and 12% of US adults have tried a GLP-1and that number keeps climbing
Enhancing the processes involved with Semaglutide aids in both weight loss and the maintenance of better regulation of blood sugar levels
Filled with over 365 unique, easy-to-follow recipes, this book is designed specifically for individuals using GLP-1 medications like Semaglutide and Tirzepatide, providing you with meals that help control blood sugar, curb cravings, and keep you on track toward achieving your goals